Abilify and Hyperbilirubinaemia neonatal - a phase IV clinical study of FDA data

Summary:

Hyperbilirubinaemia neonatal is reported as a side effect among people who take Abilify (aripiprazole), especially for people who are male, 0-1 old, have been taking the drug for 6 - 12 months also take Tylenol, and have Drug dependence.

The phase IV clinical study analyzes which people have Hyperbilirubinaemia neonatal when taking Abilify. It is created by eHealthMe based on reports of 97,308 people who have side effects when taking Abilify from the FDA, and is updated regularly.

What is Abilify?

Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 101,456 Abilify users. Check the latest studies of Abilify.

What is Hyperbilirubinaemia neonatal?

Hyperbilirubinaemia neonatal (excess of bilirubin in the blood in newborn) is found to be associated with 76 drugs and 161 conditions by eHealthMe. Check the latest studies of Hyperbilirubinaemia neonatal.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

97,308 people reported to have side effects when taking Abilify.
Among them, 12 people (0.01%) have Hyperbilirubinaemia neonatal.

Could Abilify cause Hyperbilirubinaemia neonatal?

Among these 12 people:

How long have people been on Abilify when they have Hyperbilirubinaemia neonatal? *

What is the gender of people who have Hyperbilirubinaemia neonatal when taking Abilify? *

female: 0.0 %
male: 100 %

What is the age of people who have Hyperbilirubinaemia neonatal when taking Abilify? *

What are other drugs people take besides Abilify? *

What are other side effects people have besides Hyperbilirubinaemia neonatal? *

Foetal Exposure During Pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect): 10 people, 83.33%
Drug Withdrawal Syndrome Neonatal (prenatal nas is caused by discontinuation of drugs taken by the pregnant mother): 6 people, 50.00%
Hypoglycaemia Neonatal (deficiency of glucose in the bloodstream in neonatal): 5 people, 41.67%
Neonatal Conjunctivitis (a red eye in a newborn by infection or irritation): 4 people, 33.33%
Jaundice Neonatal (yellowing of skin in neonate): 3 people, 25.00%
Transient Tachypnea Of The Newborn: 2 people, 16.67%
Strabismus (a disorder in which the two eyes do not line up in the same direction): 2 people, 16.67%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 16.67%
Craniosynostosis (a baby is born with an abnormally shaped skull or develops one during growth): 2 people, 16.67%
Visual Acuity Reduced (reduced clearness of vision): 1 person, 8.33%

What are the existing conditions these people have? *

Psychotic Disorder: 4 people, 33.33%
Drug Dependence: 4 people, 33.33%
Stress And Anxiety: 1 person, 8.33%
Schizoaffective Disorder (a mental disorder characterized by disordered thought): 1 person, 8.33%
Polycystic Ovary Disease (cysts in the ovaries that occurs when the follicle stops developing): 1 person, 8.33%
Diabetes: 1 person, 8.33%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Abilify and have Hyperbilirubinaemia neonatal?

- Check whether Hyperbilirubinaemia neonatal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Abilify:

Abilify (101,456 reports)

Browse all side effects of Abilify:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperbilirubinaemia neonatal:

Hyperbilirubinaemia neonatal (76 drugs)

Browse all the conditions that are associated with Hyperbilirubinaemia neonatal:

Hyperbilirubinaemia neonatal (161 conditions)

Related publications that referenced our studies

Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .
Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .

How the study uses the data?

The study uses data from the FDA. It is based on aripiprazole (the active ingredients of Abilify) and Abilify (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.